An experimental vaccine against the Zika virus reduced the amount of virus in pregnant rhesus macaques and improved fetal outcomes, according to a study published in the journal Science Translational Medicine. The study...
The G3P[6] rotavirus vaccine (RV3-BB) produced positive cumulative vaccine take irrespective of histo-blood group antigen (HBGA) status, according to data published in the Journal of Infectious Diseases. The association...
An experimental tuberculosis (TB) vaccine could prevent people who have TB with no sign of illness from progressing to TB of the lungs for up to three years, potentially saving millions of lives, a study shows. The WHO...
An experimental HIV vaccine developed by scientists at Scripps Research and the nonprofit vaccine research organization IAVI has reached an important milestone by eliciting antibodies that can neutralize a wide variety...
A new approach that targets young immune cells may also work for creating vaccines against the flu, dengue, malaria and hepatitis C. A collaborative team of scientists has made a successful proof-of-principle...
The vaccine rVSV-EBOV is currently used in the fight against Ebola virus. Since 2018, more than 200,000 people have been vaccinated. However, how the vaccine actually works was only partially known. The research team...
A vaccine for the common and sometimes deadly RSV (respiratory syncytial virus) has been elusive, but scientists say a new discovery puts them much closer to success. A new study from The Ohio State University provides...
A World Health Organization (WHO) advisory group, that met in Geneva to assess strains to include in the Southern Hemisphere’s 2020 flu vaccines, recommended swapping out the H3N2 component and one that covers the...
Giving children an additional dose of rotavirus vaccine when they are nine months old would provide only a modest improvement in the vaccine’s effectiveness in low-income countries concerned about waning...
After more than fifty years of trying, a potential new chlamydia vaccine has at last reached phase 1 clinical trials. Not only was the vaccine found to be safe and well-tolerated when administered to humans, it was also...